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leads to more severe inflammatory
disease.
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Altered commensal communities are associatedwith
human disease. IgA mediates intestinal homeostasis
and regulates microbiota composition. Intestinal IgA
is produced at high levels as a result of T follicular
helper cell (TFH) and B cell interactions in germinal
centers. However, the pathways directing host IgA
responses toward the microbiota remain unknown.
Here, we report that signaling through the innate
adaptor MyD88 in gut T cells coordinates germinal
center responses, including TFH and IgA+ B cell
development. TFH development is deficient in germ-
free mice and can be restored by feeding TLR2 ago-
nists that activate T cell-intrinsic MyD88 signaling.
Loss of this pathway diminishes high-affinity IgA tar-
geting of the microbiota and fails to control the bac-
terial community, leading to worsened disease. Our
findings identify that T cells converge innate and
adaptive immune signals to coordinate IgA against
the microbiota, constraining microbial community
membership to promote symbiosis.
INTRODUCTION
The development and function of the mammalian immune sys-
tem is dependent upon signals conveyed by the microbiota
(Belkaid and Hand, 2014; Hooper et al., 2012; Kamada et al.,
2013). In particular, the abundance and type of T lymphocytes
in the gut is severely reduced in germ-free (GF) mice (Atarashi
et al., 2011; Ivanov et al., 2008; Mazmanian et al., 2005; Round
and Mazmanian, 2010). While T cell activation is governed by
ligation of the T cell receptor (TCR), the quality and nature of
the response is dependent on secondary signals such as the
cytokine milieu. The identification that T cells express receptors
associated with innate signaling such as Toll-like receptors
(TLRs) and the IL-1R suggests that T cells could directly utilize
these signals as an additional mechanism to control responses
(Caramalho et al., 2003; Kubinak and Round, 2012). This would
be particularly relevant within the gut, where a constant and
abundant source of commensal ligands exists. SupportingCell Host &this, a single commensal species utilizes TLR2 to promote its
own colonization (Round et al., 2011). Recent studies have
identified that MyD88 functions within splenic T cells to over-
come Treg suppression during immunization (Schenten et al.,
2014), identifying the relevance of this pathway to immunity.
However, it remains unknown whether these signals provided
by the microbiota act directly on T cells in the gut to influence
mutualism.
The synthesis of IgA has been shown to promote intestinal
health (Berry et al., 2012; Brandtzaeg, 2013; Fagarasan et al.,
2002; Kawamoto et al., 2012; Lindner et al., 2012; Slack et al.,
2009). IgA is the most abundantly produced antibody in mam-
mals, with most being secreted into the intestine. Because of
this, IgA represents a key host mechanism for regulating
commensal microbial communities. A recent study has shown
that IgA binds colitogenic members of the microbiota (Palm
et al., 2014), which highlights the role of IgA as an important
mediator of microbiota-induced inflammatory disease and a
potential diagnostic biomarker. T cell help is required for the gen-
eration of high-affinity antibody production. In particular, TFH
cells directly interact with B cells in the germinal center (GC) to
induce somatic hypermutation and class switching (Crotty,
2011). Our understanding of the molecular pathways that influ-
ence GC formation in the gut and how the microbiota influences
these pathways remains incomplete.
In this present study, we identify that a classic innate immune
molecule, MyD88, can function within the T cell compartment in
the gut. Loss of MyD88 signaling in T cells leads to reductions in
TFH cells and IgA-producing B cells, demonstrating a key role for
molecular pathways that converge on this adaptor molecule
leading to appropriate GC formation. Moreover, GC formation
in the gut is orchestrated by signals provided by the microbiota
in a T cell-intrinsic MyD88-dependent manner. Loss of GC
formation leads to reduced IgA production and disrupted target-
ing of commensal bacterial populations. Animals lacking MyD88
within the T cell compartment fail to control mucosally associ-
ated communities of bacteria, resulting in dysbiosis. Finally, we
demonstrate that animals lacking T cell-intrinsic MyD88 develop
worsened disease that can be rescued by a microbial transplant
from a healthy donor. Thus, we have identified a host molecular
pathway that can integrate signals from the microbiota to pro-
mote GC formation and IgA production against intestinal bacte-
ria to control the composition of these communities to ensure a
benign symbiotic interaction.Microbe 17, 153–163, February 11, 2015 ª2015 Elsevier Inc. 153
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Figure 1. T Cells Utilize MyD88 Signaling to
Coordinate Germinal Center Responses
(A–C) GC-TFH cells from PPs, defined by
CD3+CD4+B220CXCR5hiPD-1hi, were measured
by flow cytometry. (A) Representative plots were
previously gated on CD3+CD4+B220 cells. (B)
Frequency and (C) absolute numbers of GC-TFH
cells are shown (n = 21 WT, n = 18 T-MyD88/).
(D–F) GC B cells, defined by B220+IgDlowFas+GL-
7+, from PPs were measured by flow cytometry.
(D) Representative plots were previously gated on
B220+IgDlow cells. (E) Frequency and (F) absolute
numbers of GC B cells are shown (n = 21 WT,
n = 18 T-MyD88/).
(G–J) IgA+ plasmablasts, defined as B220
CD138+IgA+, within the siLP and cLP were
measured by flow cytometry (G). Representative
plots were previously gated on CD138+B220
cells from siLP. (H) Frequencies of IgA+ plasma-
blasts in siLP are shown (n = 6 WT, n = 7
T-MyD88/). (I) Representative plots were previ-
ously gated on CD138+B220 cells from cLP. (J)
Frequencies of IgA+ plasmablasts in cLP are
shown (n = 8 WT, n = 5 T-MyD88/). Unpaired
two-tailed Student’s t tests were used for all
comparisons. p < 0.05 (*); p < 0.01 (**); p < 0.001
(***). Lines in scatterplots represent means. See
also Figures S1–S4.RESULTS
MyD88-Dependent Signaling in T Cells Influences GC
Responses in the Gut
Whether innate signaling by T cells influences the establishment
of beneficial bacterial communities and host health remains
to be elucidated. As MyD88 is a key molecule that governs
signaling through multiple innate receptors, we crossed
a MyD88-floxed animal with a T cell-specific Cre-driver to
produce an animal model where MyD88 is specifically knocked
out within T cells but retained in other cell types (the
T-MyD88/ mouse) (Figure S1) (Chang et al., 2013; Schenten
et al., 2014). This allowed us to test whether innate and adap-
tive immune pathways converge to promote host-microbiota
symbiosis within the gut. Recent studies have identified that
T cell-intrinsic MyD88 signaling influences systemic induction
of TH1 and TH17 cells during immunization (Chang et al., 2013;
Raetz et al., 2013; Schenten et al., 2014). Thus, we first broadly
examined CD4+ T cell development during steady-state condi-
tions. We did not observe differences in TH17, TH1, or T regula-
tory cells (Tregs) within the spleen, mesenteric lymph nodes154 Cell Host & Microbe 17, 153–163, February 11, 2015 ª2015 Elsevier Inc.(MLNs), or colonic lamina propria (cLP)
(Figures S2 and S3). Consistent with pre-
vious reports, we observed slight de-
fects in the abundance of TH1 and TREGS
within the small intestinal lamina propria
(siLP) and TH17 cells within the Peyer’s
patch (PP) (Figure S3) (Reynolds et al.,
2010; Schenten et al., 2014). However,
the most striking difference observed
was within the TFH cell compartment inboth the PP and MLNs in T-MyD88/ animals (Figure 1A and
Figures S4A–S4K). TFH cells are one of the most abundant sub-
sets of CD4+ helper T cells within the PPs and play a funda-
mental role in the generation of antibody-mediated responses
against the microbiota (Crotty, 2011; Linterman et al., 2012).
Therefore, we focused our analysis on GC formation in the
gut. TFH cells are broadly characterized by the expression of
two or more of the following surface markers: ICOS, CXCR5,
and PD-1. Subtypes of TFH cells can be delineated using
these markers. These include GC-resident TFH (GC-TFH) cells
(CXCR5hi PD-1hi) whose function is to promote class switching
and somatic hypermutation of naive B cells to produce high-
affinity IgA, and non-GC-resident TFH (non-GC-TFH) cells
(CXCR5intPD-1int) that will ultimately migrate into the GC to pro-
mote B cell activity (Shulman et al., 2013). Any combination of
these markers identifies a defect in any TFH subset in the PPs of
T-MyD88/ animals that cannot be accounted for by changes
in PP cellularity (Figures 1A–1C and Figures S4A–S4I). These
data suggest that T cell-intrinsic MyD88 signaling impacts mul-
tiple stages of TFH development. Importantly, these effects
were gut specific because they were not observed in the spleen
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Figure 2. Microbiota-Dependent TFH Devel-
opment Relies on T Cell-Intrinsic MyD88
Signaling
(A–C) GC-TFH cells from PPs, defined by
CD3+CD4+B220CXCR5hiPD-1hi, were compared
between SPF and GF Balb/c mice with flow cy-
tometry. (A) Representative plots were previously
gated on CD3+CD4+B220 cells. (B) Frequency
and (C) absolute numbers of GC-TFH cells are
shown (n = 5 SPF, n = 7 GF).
(D) GC-TFH cells from PPs were compared be-
tween SPF and GF C57BL/6 mice with flow cy-
tometry (representative plots not shown) to obtain
absolute numbers of GC-TFH cells (n = 5 for each
group).
(E–G) GC-TFH cells from PPs were compared be-
tween SPF mice treated with oral antibiotics (ABX)
and non-treated SPF animals with flow cytometry.
(E) Representative plots were previously gated
on CD3+CD4+B220 cells. (F) Frequency and (G)
absolute numbers of TFH cells are shown (n = 8
SPF, n = 9 ABX).
(H) Pam3CSK was provided in the drinking water
of GF animals for 2 weeks to calculate absolute
numbers of TFH cells in animals given TLR ligand
(+) (n = 6) or not () (n = 8).
(I) Experimental schematic showing GF Rag/
mice reconstituted with either WT or T-MyD88/
bone marrow and subsequently treated with TLR2
ligand, Pam3CSK, in the drinking water.
(J–L) GC-TFH cells from MLNs were compared
between GF Rag/ mice reconstituted with WT
or T-MyD88/ bone marrow and fed the TLR2
ligand Pam3CSK. (J) Representative plots were
previously gated on CD3+CD4+B220 cells. (K)
Frequency and (L) absolute numbers of GC-TFH
cells are shown (dotted line represents the number
of cells within these populations when GF-Rag
mice are given bone marrow for either genotype
and not stimulated) (n = 4 WT and n = 3
T-MyD88/). p < 0.05 (*); p < 0.01 (**); p < 0.001
(***). Lines in scatterplots and bar graphs repre-
sent means.(Figures S4L and S4M), indicating that T cell-intrinsic MyD88
signaling influences steady-state development of TFH cells in
the intestine.
TFH-dependent instruction of GC B cells induces IgA
+ plasma-
blast migration to the lamina propria of the small and large intes-
tine, leading to secretion of high-affinity IgA into the intestinal
lumen. Based on the observed deficiencies in TFH development,
intestinal B cell function was examined. Percentages and abso-
lute numbers of PP GC B cells were significantly reduced in
T-MyD88/ mice (Figures 1D–1F), indicating a defect in the
GC response. Consequently, IgA+ plasmablasts in the siLP and
cLPwere also diminished (Figures 1G–1J). These results demon-
strate that MyD88 signaling within T cells regulates appropriate
GC formation within the gut.
Microbiota-Derived Signals Influence the Presence of
TFH Cells in the Gut
B cell responses within the gut are sensitive to the presence of
the microbiota. Indeed, GF mice have fewer B cells and lowerCell Host &IgA levels. MyD88 functions downstream of TLRs, which are
involved in responses to bacterial products. Thus, our observa-
tions suggest that TFH development within the gut is influenced
by signals from the commensal microbiota. To test this we iso-
lated PPs from either GF or specific pathogen free (SPF) mice
from two different backgrounds of animals (Balb/c and C57BL/
6) and examined the TFH population. Both C57BL/6 and Balb/c
GF mice had significantly reduced numbers of GC-TFH cells
within the PPs when compared to SPF mice (Figures 2A–2D).
Moreover, GC-TFH cell populations were severely reduced
when C57BL/6 SPF animals were treated with an antibiotic
cocktail that depletes the microbiota (Figures 2E–2G). This dem-
onstrates that development and maintenance of GC-TFH cells
within the gut is promoted by the presence of commensal
organisms.
To determine whether live bacterial colonization is required
for induction of GC responses or whether bacterial products
alone are sufficient, we placed the TLR2 ligand, Pam3CysK, in
the drinking water of GF mice. Oral treatment of GF mice withMicrobe 17, 153–163, February 11, 2015 ª2015 Elsevier Inc. 155
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Figure3. IgAProductionagainstCommensal
Antigens Is Perturbed in the Absence of
MyD88 Signaling in T Cells
(A) Concentrations of soluble IgA within gut
lumenal contents measured by ELISA and
normalized to fecal weight (n = 20 per group).
(B) Experimental schematic showing GF Rag/
mice reconstituted with either WT or T-MyD88/
bone marrow and subsequently mono-colonized
with B. fragilis-OVA.
(C) Raw abundances of DNA specific to the OVA
gene were detected via qRT-PCR to quantify
the loads of B. fragilis-OVA per 50 ng of fecal DNA
(n = 5 per group).
(D) ELISA was used to measure the concentration
of IgA within the lumen of these animals, normal-
ized to fecal weight (n = 5 per group).
(E) Abundance of OVA-specific IgA within gut
lumenal contents measured by ELISA and
normalized to fecal weight. Data are shown as
absorbance at 450 nm (n = 5 per group).
(F) IgA-bound bacteria in intestinal lumen was
measured by flow cytometry. Representative plots
were previously gated on SYBR Green+ events
( = bacteria).
(G) Frequencies of IgA-bound bacteria (n = 8 per
group) with dashed line showingmean nonspecific
binding in RAG/ controls. Unpaired two-tailed
Student’s t tests were used for all comparisons.
p < 0.05 (*); p < 0.01 (**); p < 0.001 (***).
Lines in scatterplots represent means. Bar graphs
represent means ± SD.a purified TLR2 agonist alone was capable of significantly
increasing GC-TFH abundance within PPs (Figure 2H). To defin-
itively test the relevance of T cell-intrinsic MyD88 signaling
during microbiota dependent TFH development in vivo, we re-
constituted GF Rag/ mice with bone marrow from either WT
or T-MyD88/ animals (Figure 2I). As GF Rag/ animals do
not develop PPs and a bone marrow reconstitution does not
correct this, we analyzed the defect in TFH development within
the MLNs of these mice. Eight weeks after transfer, animals
were orally treated with a purified TLR2 agonist. Strikingly, TFH
development occurred in GF WT animals in response to purified
TLR2 ligands, while TFH development was not induced in TLR2-
treated GF animals reconstituted with T-MyD88/ bone
marrow (Figures 2J–2L). This was not a result of differences
in reconstitution of GF Rag/ animals, as baseline TFH
abundance is the same in Rag/ animals receiving WT or
T-MyD88/ bone marrow in the absence of TLR2 treatment
(Figure 2L). Collectively, these data argue strongly that cues
from the microbiota can act through MyD88 within T cells to
coordinate TFH biology, thus identifying a pathway by which
commensal bacteria can directly influence GC responses within
the intestine.156 Cell Host & Microbe 17, 153–163, February 11, 2015 ª2015 Elsevier Inc.T Cell-Intrinsic MyD88 Signaling
Coordinates IgA Responses against
the Microbiota
GC responses functionwithin the intestine
to produce high-affinity IgA against food,
self, and microbial antigens (Bemarket al., 2012). As animals that lackMyD88within theTcell compart-
ment have reduced TFH and B cell responses within the gut, we
wished to test whether these deficiencies resulted in impaired
IgA production. Intestinal contents were isolated from WT and
T-MyD88/ and analyzed for the production of secretory IgA
(SIgA) by ELISA. We found that total SIgA was reduced in
T-MyD88/ mice (Figure 3A), illustrating the importance of this
pathway in T cells for the generation of productiveGC responses.
To determine whether this pathway regulates the generation of
antigen-specific IgA against the microbiota, we mono-colonized
GFRag/mice previously reconstitutedwithWT or T-MyD88/
bone marrow with a commensal bacteria strain that was
engineered to express themodel antigen ovalbumin (Bacteroides
fragilis-OVA). This allowed us to track a commensal-specific anti-
body response (Figure 3B). GF Rag/ animals have no detect-
able OVA-specific IgAwithin the intestine (data not shown). While
B. fragilis-OVA colonization in the lumen was similar between
cohorts (Figure 3C), there was a complete absence of OVA-spe-
cific SIgA production in mono-associated T-MyD88/ animals
(Figure 3D), despite similar levels of total SIgA being produced
(Figure 3E). These data indicate that MyD88 signaling within
T cells directs antigen-specific SIgA against the microbiota.
AC
B Figure 4. Innate Recognition by T Cells In-
fluences the Composition of Mucosally
Associated Microbial Communities
(A) Principal coordinates plot of unweighted Uni-
Frac distances shows separation of microbial
communities by genotype and sample type within
separately housed animals. See also Table S1.
(B) Mucosal communities are more similar than
fecal communities (non-parametric t test; **p <
0.001, ***p = 0.0001). Boxplot whiskers = inter-
quartile range.
(C) Differences in mucosal communities between
genotypes are maintained in cohoused animals
(PERMANOVA; p = 0.0111). See also Table S1.Reports have indicated that IgA targeting of the microbiota is
modulated during intestinal disease in humans (van der Waaij
et al., 2004) and may target colitogenic members of the micro-
biota (Palm et al., 2014). SIgA can be produced in the intestine
as a result of either T cell-dependent (TD) or -independent (TiD)
mechanisms (Mantis et al., 2011; Stephens and Round, 2014).
TiD often results in low-affinity, cross-reactive antibody. TD re-
sponses, mediated by TFH cells, result in commensal targeting
via specific, high-affinity IgA binding (Lycke and Bemark,
2012). To better characterize the TD antibody defect in T-
MyD88/ animals, we utilized a flow cytometry-based assay
to look at host-generated SIgA against the microbiota. T cell-
deficient animals have undetectable IgA-bound bacteria with
this method, so this assay quantifies high-affinity TD antibody
production (Slack et al., 2009, 2012). The microbiota was iso-
lated from animals and immunostained with antibody against
IgA and treated with the DNA dye SYBR Green. Consistent
with other reports (Palm et al., 2014), 1%–10% of SYBR+ micro-
biota was bound by IgA in WT mice, while a 10-fold reduction in
IgA targeting of the microbiota was observed in T-MyD88/
animals (Figures 3F and 3G). These results reveal that innate
recognition of commensal products by T cells influences the
abundance and quality of the TD SIgA response toward
commensal bacteria.
MyD88 within T cells Prevents Dysbiosis of Tissue-
Associated Microbial Communities
Defects in commensal-directed SIgA might have important ef-
fects on the microbial ecology of the gut (Cerutti et al., 2011;
Cullender et al., 2013; Fagarasan et al., 2002; Peterson et al.,
2007). Therefore, we sought to determine via high-throughput
16S rRNA sequencing whether the loss of T cell-intrinsic
MyD88 signaling could influence microbial composition. To con-
trol for differences in bacterial communities based on housing
conditions, we performed analyses on separately housed ani-
mals whose breeding lineswere originally derived from heterozy-Cell Host & Microbe 17, 153–163,gote crosses as well as cohoused
animals. Regardless of housing condi-
tions, fecal and mucosal communities
were distinct in both genotypes (Figure 4A
and Table S1). Interestingly, greater vari-
ation exists between fecal communities
among individuals when compared to
mucosa-associated communities (Fig-ure 4B). Since mucosal communities reside in closer proximity
to host tissue, this result suggests that the immune system ex-
erts stronger selection on community membership at this site.
Consistent with this, the differences in community composition
between genotypes are only maintained in mucosa-associated
communities (Figure 4C), but not fecal communities (Table S1),
during cohousing. Among these differences, we observed
increases in multiple taxa containing mucolytic members in T-
MyD88/ animals, including Desulfovibrionaceae andMucispir-
illum (Figures S5A and S5B), as well as significant increases in
Ruminococcus (Figures S5A and S5B). Collectively, these data
indicate that loss of T cell-intrinsic TLR signaling results in signif-
icant shifts in microbial composition in the gut.
T Cell-Intrinsic MyD88 Signaling Governs IgA Targeting
of Mucosa-Associated Microbiota
We next investigated how innate signaling in T cells would influ-
ence SIgA targeting of microbial communities. To do this, we
developed an assay to purify IgA-bound bacteria with 94%purity
(Supplemental Information) and characterized SIgA-targeted
bacterial communities via high-throughput sequencing. IgAbinds
adistinctgroupofbacteriawhencompared toeither the total fecal
or mucosal community in either genotype, indicative of specific
targeting of commensal species by SIgA (Figure 5A and Table
S1). Additionally, the assemblage of bacterial species targeted
by the host via SIgA is altered in T-MyD88/ mice compared to
WT animals (Figure 5A). The SIgA-bound fraction is more similar
to the mucosa-associated community than the fecal community
inWT animals, indicating that SIgA tends to targetmucosa-asso-
ciated organisms more so than fecal community members (Fig-
ure 5B). Remarkably, this IgA bias toward mucosal communities
is lost in T-MyD88/ animals as IgA-bound species are equally
representative of mucosal and fecal communities (Figures 5B).
This is not just a result of blending of the mucosa-associated
and fecal communities, because these communities are as dis-
similar in T-MyD88/ animals as they are in WT animalsFebruary 11, 2015 ª2015 Elsevier Inc. 157
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Figure 5. T Cell-Intrinsic MyD88 Signaling Regulates IgA Selection of the Microbiota
(A) PCoA plot of unweighted UniFrac distances comparing IgA-bound and mucosa-associated bacterial communities between genotypes (PERMANOVA;
p < 0.01 for all pairwise comparisons). See also Table S1.
(B) Community dissimilarity (weighted UniFrac distance) between IgA-bound versus fecal and IgA-bound versus mucosal communities for each genotype.
Non-parametric t test. p = 0.0001 (****). Increasing values along the y axis represent increasing community dissimilarity among individual samples within a given
cohort. Boxplot whiskers = interquartile range.
(C) UniFrac distances between fecal and mucosal communities are not significantly different between genotypes (non-parametric t test). Boxplot whiskers =
interquartile range.
(D) Plot of the mean relative abundance of individual OTUs in all mucosal and IgA-bound samples colored by class of the OTU. A linear model fit to the data is
shown and is plotted on log scale.
(legend continued on next page)
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Figure 6. Phenotypic Variation in Immune Response Correlates with Microbial Community Similarity
(A) Phylogenetic diversity in mucosal communities is correlated with GC B cell abundance (%).
(B) Left: A representative plot defines the axes and pairwise comparisons used to derive results of a Mantel’s test. Right: Correlations and p values for the
association between the differences in immune response (IR) and community dissimilarity among individuals. IR dissimilarity and community dissimilarity are
estimates calculated from distance matrices built from immune phenotype and microbial community phylogenetic (UniFrac) data, respectively.(Figure 5C). These results indicate that the host IgA response is
primarily directed toward specific bacteria within the mucosa
and that this bias is disrupted in T-MyD88/ animals.
Given these results, we focused on how a loss of IgA mucosal
bias, as seen in T-MyD88/ animals, would influence the micro-
bial community. There is a significant positive correlation be-
tween bacterial species (OTU) abundance in the total mucosal
community and in the IgA-bound fraction, which implies that in
general IgA binds the most abundant organisms (Figure 5D).
Additionally, several taxonomic groups were targeted differently
betweenWT and T-MyD88/ animals (Figure 5E). These include
reduced binding of the classes Clostridia and Actinobacteria and
more robust targeting of many OTUs in the Bacteroidia (primarily
within the uncultured S24-7 family) in T-MyD88/ animals (Fig-
ure 5E). Resolution of microbial communities at finer taxonomic
depth reveals a reduction of IgA targeting of Bifidobacterium
pseudolongum and increased IgA binding of Ruminococcus
gnavus and unclassified Prevotella species in T-MyD88/ ani-
mals (Figure 5E and Figure S5A). Additionally, OTUs of the genus
Lachnospiraceae were the most differentially targeted by IgA
(including cohoused animals) (Table S2), as has been observed
in a mouse model of colitis (Berry et al., 2012). Differences in
IgA targeting in T-MyD88/ animals did not simply reflect signif-
icant differences in OTU abundance in the mucosa-associated
community (Figure 5E), suggesting that abundance alone
does not dictate the specificity of IgA targeting. Importantly,
we observed significantly increased dissimilarity among individ-
ual T-MyD88/ animals in both their IgA-bound and mucosa-
associated communities compared to WT animals (Figure 5F),
suggesting that there is greater variability in which species
persist in the gut of a T-MyD88/ animal. We also observed
an increased total bacterial load at the mucosa in T-MyD88/
animals (Figure 5G). Collectively, these data demonstrate that
innate signaling by T cells dictates IgA specificity to constrain
the composition of the microbial community, while also limiting
mucosal association of commensal microbes.(E) Class, genus, and species abundances detected as significantly different in
associated communities. Welch’s t test. p < 0.05 (*); p < 0.001(***). Bar graphs re
(F) Comparison of community dissimilarity between genotypes for IgA-bound and
(***); p = 0.0001 (****). Boxplot whiskers = interquartile range.
(G) Total bacterial load in mucosa of WT and T-MyD88/ animals as measured
Cell Host &We next sought to determine whether any of the observed
defects in the host humoral response were associated with
changes in microbial community composition. Consistent with
previous reports, we found a significant positive correlation
between the relative abundance of GC B cells and mucosal
community diversity (Figure 6A). This implies that a stronger
GC response promotes diversity, perhaps by opening niches
for rare species by limiting the densities of abundant members.
Similarly, we utilized a Mantel’s test to demonstrate that the
magnitude of difference in immune phenotype among individuals
was positively associated with dissimilarity between microbial
communities (Figure 6B). This effect was observed for multiple
immune parameters and was driven by differences between
host genotypes (Figure 6B). Thus, differences in microbial
composition between WT and T-MyD88/ animals are directly
associated with differences in their immune response. Collec-
tively, these data demonstrate that host humoral responses
sculpt microbial communities in the gut through IgA-mediated
selection and that innate sensing of microbial products by
T cells regulates this process.
Alterations to the Microbiota in T-MyD88–/– Animals
Results in Increased Intestinal Disease
Changes tomicrobial communities have been shown to promote
inflammatory disease in the gut. Our observed shifts in Lachno-
spiraceae are similar to those seen in colitogenic animals, and
R. gnavus has been associated with intestinal disease in humans
(Hansen et al., 2013; Png et al., 2010). Moreover, defects in
antibody targeting of bacteria have been seen in patients with
IBD (Harmsen et al., 2012; van der Waaij et al., 2004), suggesting
that a reduced ability to control the microbiota within T-
MyD88/ animals could lead to harmful consequences to the
host. To determine whether changes in microbial community
composition observed in T-MyD88/mice led to worsened dis-
ease, we examined colitis susceptibility in this model. Typical of
the TNBS colitis model in C57BL/6 animals, WT animals lostthe IgA-bound fraction are shown along with their abundances in mucosa-
present mean taxa abundance ± SD. See also Table S2.
mucosa-associated communities. Non-parametric t test. p < 0.05 (*); p < 0.001
by qPCR. Student’s t test. p < 0.05 (*). Bars represent means.
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Figure 7. Increased Intestinal Disease Observed in T-MyD88–/–
Animals Is Dependent on the Composition of the Microbiota
(A) TNBS-induced weight loss (represented as the percentage of initial weight)
was compared among WT and T-MyD88/ animals. EtOH vehicle controls
are shown for comparison. Points represent means ± SEM (representative of
two independent experiments).
(B) Representative H&E-stained colon sections from WT and T-MyD88/
mice following TNBS-induced colitis.
(C) Histology scores reflecting disease severity for TNBS-treated animals
(WT animals, n = 10; T-MyD88/ animals, n = 11; T-MyD88/ animals
with WT microbiota transplant, n = 8; T-MyD88/ animals with T-MyD88/
microbiota transplant, n = 7). Dotted line represents scores for mice treated
with EtOH only. A Student’s t test was used for all comparisons. p < 0.05 (*);
p < 0.01 (**); p < 0.001 (***).10% of their body weight and quickly regained their original
mass. However, T-MyD88/ animals lost more weight and did
not recover toWT levels by the end of the experiment (Figure 7A).160 Cell Host & Microbe 17, 153–163, February 11, 2015 ª2015 ElseHistological analysis of these colons revealed that T-MyD88/
mice had increased inflammatory infiltrate and greater crypt
loss than WT animals (Figures 7B and 7C). Increased bacterial
loads at the mucosa or differences in the assemblage of species
living at this site could explain this. To determine whether micro-
bial composition in the gut influenced disease progression,
we tested whether susceptible T-MyD88/ animals could be
rescued with a WT microbiota. To this end, cohorts of T-
MyD88/ animals were treated with antibiotics to clear endog-
enous commensals and subsequently given a transplant with
either WT or T-MyD88/ microbiota. Animals that received a
microbial transplant from a T-MyD88/ animal developed se-
vere crypt loss (Figures 7B and 7C). Remarkably, the extent of
disease observed in T-MyD88/ animals provided a microbiota
from WT mice was significantly reduced and indistinguishable
from that observed in WT animals (Figure 7C). Notably, WT GF
mice given a T-MyD88/ microbiota had no difference in dis-
ease severity (data not shown), indicating that the microbial
composition formed in T-MyD88/ animals is not sufficient to
cause disease in an immune-competent host. Thus, this model
closely mirrors the complexity seen in human IBD whereby ge-
netic and environmental factors interact to promote disease.
These data also highlight the potential curative value of fecal
transplantations from healthy donors.
DISCUSSION
While originally thought to play a role only within the innate
immune compartment, emerging data support that MyD88 func-
tions also in cells of the adaptive immune system such as T lym-
phocytes (Chang et al., 2013; Schenten et al., 2014). How this
pathway could function to influence resident commensal com-
munities has remained unexplored. MyD88 functions down-
stream of multiple receptors including the cytokine receptors,
IL-1, IL-18, and IL-33, as well as all the TLRs with the exception
of TLR3. The microbiota is an abundant source of TLR ligands
and can induce the basal expression of these cytokines, making
MyD88 an attractive molecule to integrate multiple signals
induced by the microbiota to directly control host T cell function.
Indeed, here we identify that MyD88 signaling in T cells governs
the development of functional GCs within the gut. It is unclear at
this stage what exact signals are triggering activation of MyD88
within T cells to control GC responses. However, it is likely that
multiple signals act directly on T cells and converge on MyD88
as T cells express several of these TLRs and cytokine receptors
(Reynolds et al., 2010). The use and development of new condi-
tional animal models to study these individual signals will be
required to fully understand how innate signals elicited by the
microbiota can directly influence T cell development and func-
tion within the gut.
One of the primary mechanisms to promote homeostasis
within the gut is through the production of antigen-specific
IgA. Understanding the mechanisms by which this pathway gov-
erns antigen-specific TFH responses will be an important future
endeavor. By employing a newly developed technology, we
were able to determine that antigen-specific IgA toward the
microbiota is influenced by MyD88 in T cells (Cullender et al.,
2013; Kawamoto et al., 2012; Palmet al., 2014). There is evidence
that there are niche-specific microbial communities within thevier Inc.
gut, including organisms that are in close proximity to the host
(tissue- or mucosa-associated communities) and those that are
found to reside away from the host within the intestinal lumen.
We identify that host IgA tends to target tissue-associatedmicro-
bial communities in a healthy animal. However, in the absence of
MyD88 signalingwithin the T cells, themucosal bias of IgA is lost,
indicating that this pathwayserves todictate IgAspecificitywithin
the gut. More importantly, loss of this signaling pathway in T cells
leads to defective control over microbial community composi-
tion, resulting in worsened intestinal disease.
Immune systems evolved within a microbe-dominated world
under strong selection to protect host tissues from pathogenic
invasion. However, the dependence of host health on the micro-
biota strongly suggests that the immune system evolved to serve
an additional purpose: to promote colonization bymicrobial spe-
cies whose presence can be exploited to benefit host health
(McFall-Ngai et al., 2013). Thus, coevolutionary forces between
resident microbes and hosts have resulted in mechanisms to
respond to one another, creating a flexible dialog to ensure
stability of symbiosis. IgA represents one host tool to directly in-
fluence bacterial communities; however, it has been unclear
whether IgA binds to specific members of the community and,
more importantly, what host molecular machinery governs this
specificity. Our data support a model whereby signals from
commensal microbes are perceived directly by host T cells
to promote the production of TFH and GC B cell responses,
leading to the generation of high-affinity IgA toward commen-
sals. This represents an important mechanism through which
hosts can maintain a benign assemblage of microbial species
in the gut.
Segregation of innate and adaptive arms of the immune
system would be appropriate in sterile environments (like the
systemic compartment) as this would provide a binary switch
to respond to microbial invasion. However, in tissues with
persistent bacterial exposure, cellular convergence of innate
and adaptive immune pathways could provide more flexibility
to fine-tune antigen-specific signaling and respond to environ-
mental changes properly. Thus, modulation of T cell responses
through microbiota-derived signals might provide a therapeutic
target to prevent disease associated with human autoimmunity.EXPERIMENTAL PROCEDURES
Animal Models
MyD88fl/fl (Jackson Labs) mice were crossed to CD4-cre+mice (Taconic) (both
on C57BL/6 background) to produce the T-MyD88/ (MyD88fl/fl-CD4cre+)
mouse model. MyD88+/+-CD4-cre+ mice were used as wild-type (WT) controls
for all comparisons. GF animals were on a C57BL/6 background except when
noted in the figure legend. Animal use adhered strictly to federal guidelines and
those set forth by the University of Utah’s Institutional Animal Care and Use
Committee.
In Vitro Activation Experiments
Purified cells were plated in 250 ml of supplemented RPMI containing 20 ng/ml
IL-2 in 96-well plates (23 105 cells per plate) that had been previously coated
with 5 mg/ml purified anti-CD3. For TFH skewing conditions, 1 mg/ml of the
costimulatory antibody anti-CD28, 5 mg/ml anti-CD3e, 10 mg/ml anti-IFNg,
50 ng/ml IL-21, and 50 ng/ml IL-6 were added. For TLR ligand stimulation,
1 mg/ml of either Pam2CSK (Invivogen), Pam3CSK (Invivogen), flagellin from
S. Typhimurium (Invivogen), or LPS (Invivogen) was added. Cells were cultured
for 4 days at 37C in these conditions before being analyzed by flow cytometry.Cell Host &RNA Isolation and RNA-Sequencing of Purified TFH Cells
mRNA was collected from 50,000 TFH cells with the QIAGEN miRNeasy Mini
Kit (QIAGEN) following kit instructions. mRNA was prepared following QC
via an Illumina TruSeq Stranded RNA Sample Prep with RiboZero treatment
(human, mouse, rat, etc.) and analyzed with Illumina HiSeq Sequencing.
Disease Model-TNBS Colitis
One hundredmicroliters of a 50/50 (v/v) mixture of EtOH and TNBSwas admin-
istered intra-rectally on days 0 and 5. Weights were collected daily for the first
5 days, and tissue was collected on day 7. Animals were scored as described
in detail in the Supplemental Information and as reported in Round and Maz-
manian, 2010.
GF Model
GFmiceweremaintained in sterile isolators and assayedmonthly for GF status
by plating and PCR. Balb/c GF mice were compared to SPF mice to measure
TFH cells. GF Rag1
/ mice from the C57BL/6 background were given bone
marrow fromWT or T-MyD88/mice and allowed to reconstitute for 8 weeks.
Mice were either given Pam3CSK in their drinking water or were gavaged with
B. fragilis-expressing OVA.
Quantification of IgA+ Fecal Bacteria
Fecal microbiota were stained with SYBR Green dye and a PE-conjugated IgA
antibody to enumerate IgA-coated bacteria via flow cytometry. Please see
detailed Supplemental Experimental Procedures.
Sequencing of Microbiota Communities
DNA was extracted with bead beating methods from fecal, mucosal, and IgA-
bound enriched samples from each animal. The V3 and V4 regions of the bac-
terial 16S rRNA gene were amplified and sequenced on an Illumina MiSeq with
300 cycles from each end. Sequences were processed and analyzed with
mothur 1.32 (Schloss et al., 2009) and Qiime 1.8.0 (Caporaso et al., 2010).
Statistical Analysis
Figure creation and statistical analysis were performed with the Prism6.0 sta-
tistical software, R 3.1.0, STAMP 2.0.5 (Parks and Beiko, 2010), and utilities
within the Qiime software. Unpaired two-tailed Student’s t tests were used
for statistical comparisons unless otherwise noted (see Supplemental Informa-
tion). Non-parametric t tests were performed with 9,999 Monte Carlo simula-
tions. All statistical tests, and estimates of dispersion, are referenced in the
figure legends.
Animal Housing/Cohousing Experiments
SPFmice in our facility are housed under identical conditions and fed the same
diet, whichminimizes the effect of environmental variability on host phenotypes
and microbial communities. In an effort to standardize any potential effect of
isolation (across cages and between genotypes) on microbiota communities,
multiple independent homozygous WT and T-MyD88/ breeder pairs were
set up at the same time from initial heterozygous crosses. Clustering of geno-
types in 16S microbiota analysis confirms that host genotype and not isolation
is the primary driver of differences among individuals in their communities. For
cohoused experiments, pregnant homozygous WT or T-MyD88/ animals
gave birth to litters in the same cage (births occurred within 1 week of each
other). Animals remained in the same cage until weaning (4 weeks of age)
and were subsequently housed separately until analysis (8 weeks of age).
Lamina Propria Lymphocyte Isolation
Lamina propria lymphocytes (LPLs) were isolated with a combination of two
previously described methods (Atarashi et al., 2011; Round et al., 2011). Prior
to LPL isolations of small intestines (SI), all visible Peyer’s patches were
removed. Colons and SI tissue were opened longitudinally and mucus was
removed by gently scraping and then rinsing in sterile 1X HBSS. The tissue
was cut into small pieces and incubated in sterile 1X HBSS (without Ca2+
and Mg2+) containing 5 mM EDTA (Cellgro) and 1 mM DL-Dithiothreitol (DTT)
(Sigma) for 45 min at 37C on a shaker. Supernatant was removed by filtering
through a 100 mM filter, and remaining tissue was incubated in a solution con-
taining sterile 1X HBSS containing 5% (v/v) fetal bovine serum (GIBCO BRL),
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DNaseI (Sigma) for 45 min at 37C on a shaker. The supernatant was filtered
over a 40 mm cell strainer into ice-cold sterile 1X HBSS. Cells were passed
through a Percoll (GE Healthcare) gradient (40%/80% [v/v] gradient) and
spun at 620 3 g for 20 min with no brake. Cells at the 40/80 interface were
collected and washed twice with supplemented HBSS (10 mM HEPES [Cell-
gro], 2 mM EDTA [Cellgro], and 0.5% [v/v] fetal bovine serum [GIBCO BRL])
and prepared for flow cytometry analysis. While this isolation strategy is widely
used as an approach for isolating lamina propria tissue-resident lymphocytes,
it does not prohibit contamination by lymphocytes residing within the microen-
vironment of isolated lymphoid follicles (ILFs), which are organized lymphoid
structures found throughout the lamina propria; therefore we cannot
completely exclude the possibility that some of the cells we are assaying
reside with ILFs.
Flow Cytometry Staining of Isolated Lymphocytes
Lymphocytes were isolated from the colonic and small intestinal lamina prop-
ria as mentioned above. Spleen, MLN, or Peyer’s patch tissues were gently
pushed through a 40 mM filter to obtain white blood cells. Spleen cells were
additionally treated with 1X RBC Lysis Buffer (Biolegend) to lyse and remove
red blood cells. Surface staining for lymphocytes was done in sterile 1X
HBSS (Corning) supplementedwith 10mMHEPES (Cellgro), 2mMEDTA (Cell-
gro), and 0.5% (v/v) fetal bovine serum (GIBCO BRL) for 20 min at 4C. Cells
were then washed twice in supplemented 1X HBSS and enumerated via
flow cytometry. The following antibodies were used: anti-CD4 (Biolegend:
clone GK1.5 APC/Pacific Blue, clone RM4-5 FITC; eBioscience clone RM4-5
PerCP-Cy5.5), anti-CD3 (Biolegend: 145-2C11 Pacific Blue), anti-B220 (Bio-
legend: clone RA3-6B2 PerCP-Cy5.5), anti-CD138 (Biolegend: clone 281-2
PE), anti-CXCR5 (eBioscience: clone SPRCL5 PE), anti-PD-1 (Biolegend:
RMP1-30 Pe/Cy7), anti-ICOS (eBioscience: clone 7E.17G9 FITC), anti-GL-7
(eBioscience: clone GL-7 Alexa Fluor 488), anti-Fas (BD Biosciences: clone
Jo2 PE-Cy7), anti-IgD (Biolegend: clone 11-26c.2a Alexa Fluor 647), or anti-
IgA (Southern Biotech goat anti-mouse IgA FITC). For intracellular staining,
cells were first stimulated with ionomycin (500 ng/ml), PMA (5 ng/ml), and Bre-
feldin A (5 mg/ml) (Biolegend) for 4 hr at 37C. Cells were surface stained,
washed, and then permeabilized and fixed in 100 ml Perm/Fix buffer
(eBiosciences) at 4C overnight. Cells were washed twice in Perm/Wash buffer
(eBioscience) and then stained for intracellular cytokines with the following
antibodies: anti-Foxp3 (eBioscience: clone FJK-16 s APC/PerCP-Cy5.5),
anti-IL-17A (eBioscience: clone eBio17B7 eFluor 660), or anti-IFNg (Bio-
legend: clone XMG1.2 PE). Cells were again washed twice in Perm/Wash
buffer and then placed with supplemented HBSS (10 mM HEPES [Cellgro],
2 mM EDTA [Cellgro], and 0.5% [v/v] fetal bovine serum [GIBCO BRL]) and
enumerated via flow cytometry. Gating and analysis of positive cell popula-
tions was done utilizing respective isotype controls for antibodies against
ICOS, CXCR5, GL-7, and PD-1. Other cell populations were identified with sin-
gle stain controls. These data were collected with a BD LSR Fortessa and
analyzed with FlowJo software.
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